Tag

EN14914

Cambrex Advances US and European Expansions

EAST RUTHERFORD, N.J., March 23, 2026 /PRNewswire/ — Cambrex, a leading global contract development and manufacturing organization (CDMO), today announced the completion of initial engineering studies for its new, large-scale active pharmaceutical ingredient (API) manufacturing plant in Charles City, Iowa.